Hannover Re (OTCMKTS: HVRRY) is one of 37 public companies in the “Life insurance” industry, but how does it contrast to its competitors? We will compare Hannover Re to related businesses based on the strength of its earnings, valuation, analyst recommendations, institutional ownership, profitability, dividends and risk.
This is a summary of recent recommendations for Hannover Re and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Hannover Re Competitors||317||1116||1507||82||2.45|
Earnings & Valuation
This table compares Hannover Re and its competitors gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Hannover Re||$19.66 billion||$1.08 billion||15.38|
|Hannover Re Competitors||$22.37 billion||$1.24 billion||15.59|
Hannover Re’s competitors have higher revenue and earnings than Hannover Re. Hannover Re is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Hannover Re pays an annual dividend of $1.42 per share and has a dividend yield of 2.1%. Hannover Re pays out 31.6% of its earnings in the form of a dividend. As a group, “Life insurance” companies pay a dividend yield of 2.2% and pay out 28.1% of their earnings in the form of a dividend. Hannover Re lags its competitors as a dividend stock, given its lower dividend yield and higher payout ratio.
Volatility & Risk
Hannover Re has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. Comparatively, Hannover Re’s competitors have a beta of 1.07, suggesting that their average stock price is 7% more volatile than the S&P 500.
This table compares Hannover Re and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Hannover Re Competitors||5.06%||4.82%||0.92%|
Institutional and Insider Ownership
0.1% of Hannover Re shares are owned by institutional investors. Comparatively, 48.6% of shares of all “Life insurance” companies are owned by institutional investors. 18.7% of shares of all “Life insurance” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Hannover Re competitors beat Hannover Re on 11 of the 15 factors compared.
About Hannover Re
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities. This segment also provides risk solutions for casualty and property, as well as for agricultural, livestock, and bloodstock businesses; aviation and space business; and marine and offshore energy business. The Life & Health Reinsurance segment offers, enhanced annuities, group life and health, guaranteed simplified issue, 60+, and Sharia-compliant Takaful reinsurance products, as well as micro insurance products. This segment also provides risk solutions in the areas of critical illness, disability, health, longevity, long term care, and mortality. In addition, it offers various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and divestiture of non-core businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. The company was founded in 1966 and is based in Hanover, Germany. Hannover Rück SE is a subsidiary of Talanx AG.
Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.